Eurofins-Cerep SA (ALECR) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Low Debt Company with Strong Long Term Fundamental Strength

Negative results in Dec 24

With ROE of 0.00%, it has a Fair valuation with a 1.25 Price to Book Value

Consistent Underperformance against the benchmark over the last 3 years

Mojo Parameters

Stock DNA

Industry

Miscellaneous

Market cap

EUR 85 Million ()

P/E

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.19

Return on Equity

0.00%

Price to Book

1.16

Revenue and Profits:

Net Sales:

8 Million

(Quarterly Results - Dec 2009)

Net Profit:

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-7.69%

6 Months

-18.45%

1 Year

-16.0%

2 Years

-32.8%

3 Years

-24.32%

4 Years

-9.68%

5 Years

47.37%

Eurofins-Cerep SA for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

93.75%

EBIT Growth (5y)

EBIT to Interest (avg)

Debt to EBITDA (avg)

3.84

Net Debt to Equity (avg)

-0.24

Sales to Capital Employed (avg)

0.49

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.25

EV to EBIT

EV to EBITDA

EV to Capital Employed

1.31

EV to Sales

2.97

PEG Ratio

Dividend Yield

ROCE (Latest)

ROE (Latest)

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Bearish

RSI

No Signal

Bullish

Bollinger Bands

Mildly Bearish

Moving Averages

Bearish (Daily)

KST

Mildly Bullish

Bearish

Dow Theory

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'09 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2009 is -17.39% vs 0.00% in Dec 2008",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2009 is 0.00% vs 0.00% in Dec 2008",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Dec'09",
        "Dec'08",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "7.60",
          "val2": "9.20",
          "chgp": "-17.39%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'22",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2022 is 14.42% vs 27.22% in Dec 2021",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2022 is 17.35% vs 75.00% in Dec 2021",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'22",
        "Dec'21",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "47.60",
          "val2": "41.60",
          "chgp": "14.42%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "13.30",
          "val2": "11.50",
          "chgp": "15.65%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.00",
          "val2": "-0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "11.50",
          "val2": "9.80",
          "chgp": "17.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "240.60%",
          "val2": "244.00%",
          "chgp": "-0.34%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'09 - YoY

Dec'09

Dec'08

Change(%)

Net Sales

7.60

9.20

-17.39%

Operating Profit (PBDIT) excl Other Income

0.00

Interest

0.00

Exceptional Items

0.00

Consolidate Net Profit

0.00

Operating Profit Margin (Excl OI)

0.00%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Dec 2009 is -17.39% vs 0.00% in Dec 2008

Consolidated Net Profit

YoY Growth in quarter ended Dec 2009 is 0.00% vs 0.00% in Dec 2008

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'22

Dec'22

Dec'21

Change(%)

Net Sales

47.60

41.60

14.42%

Operating Profit (PBDIT) excl Other Income

13.30

11.50

15.65%

Interest

0.00

Exceptional Items

-0.00

Consolidate Net Profit

11.50

9.80

17.35%

Operating Profit Margin (Excl OI)

240.60%

244.00%

-0.34%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2022 is 14.42% vs 27.22% in Dec 2021

Consolidated Net Profit

YoY Growth in year ended Dec 2022 is 17.35% vs 75.00% in Dec 2021

All Annual Results

Company CV

About Eurofins-Cerep SA

Eurofins-Cerep SA

Miscellaneous

Eurofins-Cerep SA, formerly Cerep SA is a France-based company that specializes in the pre-clinical research, discovery and development of new pharmaceutical drugs. The Company, using its BioPrint technology systems that analyzes pharmaceutical drugs on the market, those that have been withdrawn, and those that failed in the development stages, builds up predictive models of the potential of new drugs. These predictions are based on the drugs' chemical structure and their performance in vitro. The Company then offers solutions to the pharmaceutical and biotechnology sectors on reducing time and costs in the early stages of the drug development process. Clients can also gain access to some of the Company's technology by subscribing to BioPrint. In December 2013, it sold Cerep Inc, its American subsidiary, to Eurofins-Panlabs Inc, part of the Eurofins Scientific SE group.

Company Coordinates

Company Details

Le bois l'Eveque , CELLE-LEVESCAULT None : 86600

Tel: 33 5 49893000

https://www.eurofins.fr/cerep/

Registrar Details